CLINICAL TRIALS PROFILE FOR BIVIGAM
✉ Email this page to a colleague
All Clinical Trials for BIVIGAM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03829566 ↗ | Autologous Transplant To End NMO Spectrum Disorder | Withdrawn | Northwestern University | Phase 2/Phase 3 | 2019-11-01 | This study is designed to treat your disease with an autologous stem cell transplant using a regimen of immune suppressant drugs and chemotherapy to reset your immune system and to determine if your disease will go into long-term remission. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BIVIGAM
Condition Name
Clinical Trial Locations for BIVIGAM
Trials by Country
Clinical Trial Progress for BIVIGAM
Clinical Trial Phase
Clinical Trial Sponsors for BIVIGAM
Sponsor Name